The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2016

Filed:

Jul. 12, 2012
Applicants:

Max S. Cynader, West Vancouver, CA;

Guang Yang, Vancouver, CA;

Inventors:

Max S. Cynader, West Vancouver, CA;

Guang Yang, Vancouver, CA;

Assignee:

The University of British Columbia, Vancouver, British Columbia, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/45 (2006.01); C07K 19/00 (2006.01); C12N 9/10 (2006.01); A61K 47/48 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/1029 (2013.01); A61K 38/45 (2013.01); A61K 47/48315 (2013.01); A61K 38/00 (2013.01); C07K 2319/10 (2013.01); C07K 2319/23 (2013.01); C07K 2319/41 (2013.01); C07K 2319/70 (2013.01);
Abstract

Isolated polypeptides are disclosed herein, the isolated polypeptides comprising at least 90% identity to any one of: SEQ ID NO:1; SEQ ID NO:2; or SEQ ID NO:3, wherein the isolated polypeptide inhibits an interaction between palmitoyl acyl transferase zinc-finger DHHC type containing 17 (z D17) and c-jun N-terminal kinase (JNK). The polypeptides may be conjugated to a delivery and targeting moiety, such as the cell-membrane transduction domain of the HIV-1 Tat protein. There are also provided methods for treating a disease associated with cytotoxicity or excitotoxicity.


Find Patent Forward Citations

Loading…